AAXT Stock Overview
Aamaxan Transport Group, Inc. manufactures medical products that are used during hemodialysis therapy.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Aamaxan Transport Group, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.0001 |
52 Week High | US$0.0001 |
52 Week Low | US$0.0001 |
Beta | 0 |
1 Month Change | 0% |
3 Month Change | 0% |
1 Year Change | n/a |
3 Year Change | -99.92% |
5 Year Change | -99.96% |
Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
AAXT | US Transportation | US Market | |
---|---|---|---|
7D | 0% | -0.2% | -1.0% |
1Y | n/a | 42.2% | 26.0% |
Rentabilidad frente al sector: Datos insuficientes para determinar los resultados de AAXT en comparación con el sector US Transportation .
Rentabilidad vs. Mercado: Datos insuficientes para determinar el rendimiento de AAXT frente al mercado US.
Price Volatility
AAXT volatility | |
---|---|
AAXT Average Weekly Movement | n/a |
Transportation Industry Average Movement | 5.4% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.7% |
10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: AAXT no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: Datos insuficientes para determinar el cambio de volatilidad de AAXT en el último año.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | n/a | Chen Zhong |
Aamaxan Transport Group, Inc. Fundamentals Summary
AAXT fundamental statistics | |
---|---|
Market cap | US$1.60k |
Earnings (TTM) | US$7.39m |
Revenue (TTM) | US$39.13m |
0.0x
P/E Ratio0.0x
P/S RatioIs AAXT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
AAXT income statement (TTM) | |
---|---|
Revenue | US$39.13m |
Cost of Revenue | US$24.46m |
Gross Profit | US$14.67m |
Other Expenses | US$7.28m |
Earnings | US$7.39m |
Last Reported Earnings
Jun 30, 2008
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did AAXT perform over the long term?
See historical performance and comparison